ESMO 2026: The Breast Cancer Research We’re Watching
ESMO 2026: The Breast Cancer Research We’re Watching Breast Cancer.org
🎗️
Онкология
Рак молочной железы
677 материалов по теме, собраны автоматически из проверенных источников
Онкология
MAMMÔ 2026 Day 2 Highlights: From Adjuvant Optimization to Metastatic Breast Cancer, ADCs and Precision Treatment
MAMMÔ 2026 Day 2 Highlights: From Adjuvant Optimization to Metastatic Breast Cancer, ADCs and Precision Treatment Oncodaily
Онкология
Natera and Susan G. Komen Partner to Support People Impacted by Breast Cancer
Natera and Susan G. Komen Partner to Support People Impacted by Breast Cancer Oncodaily
Онкология
Could Breast Milk Offer a New Route to Detecting Breast Cancer Earlier – MCRC
Could Breast Milk Offer a New Route to Detecting Breast Cancer Earlier – MCRC Oncodaily
Онкология
Рак груди распространяется среди молодых женщин: актриса Элизабет Херли привлекает внимание к проблеме
Рак груди распространяется среди молодых женщин: актриса Элизабет Херли привлекает внимание к проблеме ТСН
Онкология
Это вовсе не рак: что важно знать, если на маммографии нашли изменения
Это вовсе не рак: что важно знать, если на маммографии нашли изменения Doctorpiter
Онкология
Immune Cells Feed Breast Cancer Tumors as AI and DNA Testing Reshape Cancer Care
Immune Cells Feed Breast Cancer Tumors as AI and DNA Testing Reshape Cancer Care Bioengineer.org
🎗️
Онкология
Sigrun Hallmeyer named physician lead of breast cancer at Advocate Health Enterprise
Sigrun Hallmeyer named physician lead of breast cancer at Advocate Health Enterprise The Cancer Letter
Онкология
FDA Approves Tucatinib Combo for HER2-Positive Breast Cancer Maintenance
FDA Approves Tucatinib Combo for HER2-Positive Breast Cancer Maintenance Breast Cancer Research Foundation | BCRF
Онкология
EORTC Breast Cancer Group – People Moving Breast Cancer Research Forward
EORTC Breast Cancer Group – People Moving Breast Cancer Research Forward Oncodaily
Онкология
MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care Oncodaily
Онкология
HER2+ Early Breast Cancer: Who Can Safely Receive Less?
HER2+ Early Breast Cancer: Who Can Safely Receive Less? Medscape
Онкология
Breast Cancer Is the Leading Cause of Cancer Death Among Latinas, and for Many, Treatment Doesn't End When the World Thinks It Does
Breast Cancer Is the Leading Cause of Cancer Death Among Latinas, and for Many, Treatment Doesn't End When the World Thinks It Does https://fiercebymitu.com/
🎗️
Онкология
Session 1: Estrogen Receptor Biomarker Testing, Targeting Mechanisms, and Treatment Decisions in Breast Cancer Care
Session 1: Estrogen Receptor Biomarker Testing, Targeting Mechanisms, and Treatment Decisions in Breast Cancer Care HMP Global Learning Network
🎗️
Онкология
Session 2: From ESR1 Testing to Treatment Selection: Understanding ER-Targeted Approaches in Breast Cancer
Session 2: From ESR1 Testing to Treatment Selection: Understanding ER-Targeted Approaches in Breast Cancer HMP Global Learning Network